37 results
S-3ASR
MRK
Merck & Co Inc
19 Mar 24
Automatic shelf registration
4:28pm
of Organon’s publicly traded stock to our shareholders. The established brands included in the transaction consisted of dermatology, non-opioid pain
S-3ASR
MRK
Merck & Co Inc
19 Mar 24
Automatic shelf registration
4:26pm
of Organon’s publicly traded stock to our shareholders. The established brands included in the transaction consisted of dermatology, non-opioid pain
424B5
MRK
Merck & Co Inc
10 May 23
Prospectus supplement for primary offering
4:27pm
brands included in the transaction consist of dermatology, non-opioid pain management, respiratory, and select cardiovascular products including Zetia
424B5
MRK
Merck & Co Inc
8 May 23
Prospectus supplement for primary offering
8:17am
in the transaction consist of dermatology, non-opioid pain management, respiratory, and select cardiovascular products including Zetia (ezetimibe
SD
EX-1.01
l8fvfef
20 May 22
Conflict minerals disclosure
4:06pm
424B5
istnz9 wc
9 Dec 21
Prospectus supplement for primary offering
4:37pm
424B5
1m585w740cacr7e6o5hs
7 Dec 21
Prospectus supplement for primary offering
8:13am
PX14A6G
pl5txq eb
6 May 21
Letter to shareholders
3:11pm
S-3ASR
vl2xtzxbw
25 Mar 21
Automatic shelf registration
4:46pm
S-3ASR
jpn53wxfoj2
25 Mar 21
Automatic shelf registration
4:42pm